Lineage Cell Therapeutics, Inc.
LCTX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000876343
No open-market purchases or sales by Lineage Cell Therapeutics, Inc. insiders were filed in the last 90 days; 131 institutions reported holding it in 13F filings for Q2 2026, worth $152.7M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Lineage Cell Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 123
- +13 vs. Q3 2025
- Shares held
- 101.7M
- +13.8M (+15.7%) vs. Q3 2025
- Total value
- $169.8M
- +$21.3M (+14.4%) vs. Q3 2025
- New holders
- 25
- 29 more added
- Sold out
- 12
- 28 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LCTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $152.7M |
| Q1 2026 | 130 | $176.5M |
| Q4 2025 | 123 | $169.8M |
| Q3 2025 | 112 | $148.6M |
| Q2 2025 | 129 | $88.4M |
| Q1 2025 | 127 | $49.7M |
| Q4 2024 | 126 | $53.8M |
| Q3 2024 | 114 | $85.6M |
| Q2 2024 | 113 | $94.2M |
| Q1 2024 | 116 | $138.3M |
| Q4 2023 | 115 | $82.5M |
| Q3 2023 | 104 | $89.1M |
| Q2 2023 | 107 | $106.6M |
| Q1 2023 | 116 | $104.7M |
| Q4 2022 | 106 | $76.2M |
| Q3 2022 | 104 | $73.1M |
| Q2 2022 | 100 | $102.7M |
| Q1 2022 | 109 | $112.3M |
| Q4 2021 | 124 | $182.0M |
| Q3 2021 | 115 | $191.7M |
| Q2 2021 | 115 | $208.5M |
| Q1 2021 | 102 | $141.8M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Lineage Cell Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SEI Investments Co | 269,311 | $449.7K | 0.00% | +269,311 | New |
| Omers Administration Corp | 283,200 | $472.9K | 0.00% | +283,200 | New |
| Gsa Capital Partners LLP | 330,981 | $553.0K | 0.05% | −339,875−50.7% | Reduced |
| Barclays PLC | 348,510 | $582.0K | 0.00% | +348,509+34,850,900.0% | Added |
| EAM Investors, LLC | 442,221 | $738.5K | 0.08% | 00.0% | Unchanged |
| Northern Trust Corp | 479,273 | $800.4K | 0.00% | +35,921+8.1% | Added |
| Citadel Advisors LLC | 507,052 | $846.8K | 0.00% | +313,084+161.4% | Added |
| Red Crane Wealth Management, LLC | 597,263 | $997.4K | 0.82% | +85,900+16.8% | Added |
| Susquehanna International Group, LLP | 706,415 | $1.18M | 0.00% | +521,415+281.8% | Added |
| Jane Street Group, LLC | 1,004,794 | $1.68M | 0.00% | +859,931+593.6% | Added |
| State Street Corp | 1,016,211 | $1.70M | 0.00% | +60,589+6.3% | Added |
| Marshall Wace, LLP | 1,362,061 | $2.27M | 0.00% | +1,362,061 | New |
| Goldman Sachs Group Inc | 1,438,746 | $2.40M | 0.00% | +1,294,070+894.5% | Added |
| Morgan Stanley | 1,998,663 | $3.34M | 0.00% | +992,212+98.6% | Added |
| Millennium Management LLC | 2,110,419 | $3.52M | 0.00% | −569,584−21.3% | Reduced |
| Renaissance Technologies LLC | 2,404,800 | $4.02M | 0.01% | +499,167+26.2% | Added |
| Geode Capital Management, LLC | 2,461,193 | $4.11M | 0.00% | +41,427+1.7% | Added |
| BlackRock, Inc. | 3,834,113 | $6.40M | 0.00% | +1,603,357+71.9% | Added |
| Comerica Bank | 4,600,000 | $7.68M | 0.03% | 00.0% | Unchanged |
| Raffles Associates LP | 5,362,788 | $8.96M | 6.72% | −25,000−0.5% | Reduced |
| Defender Capital, LLC. | 6,829,099 | $11.4M | 3.70% | +6,829,099 | New |
| Vanguard Group Inc | 9,644,276 | $16.1M | 0.00% | +637,346+7.1% | Added |
| Broadwood Capital Inc | 49,560,992 | $82.8M | 5.00% | 00.0% | Unchanged |
| Dauntless Investment Group, LLC | 0 | $0 | 0.00% | −1,614,100−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −28,017−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −27,121−100.0% | Sold out |
| Citizens Financial Group Inc | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Beacon Capital Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −11,823−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −11,650−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −288−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |